Why is Valiant Laborato falling/rising?

As of 25-Jun, Valiant Laboratories Ltd is currently priced at 116.45, experiencing a decline of 0.55, or 0.47%. The stock has recently underperformed its sector by 1.52% and has seen a trend reversal after three consecutive days of gains. Despite this, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating some positive momentum. The stock has shown a 3.01% increase over the past week and an 11.44% increase over the past month, although it has a significant decline of 18.59% over the past year. Positive factors include a higher profit after tax and net sales in the latest quarter, along with increased participation from institutional investors, which may provide some support. However, the company faces challenges such as weak long-term fundamental strength, negative EBITDA, and consistent underperformance against benchmarks, which contribute to the stock's current decline.
In the broader market context, Valiant Laboratories Ltd has outperformed the Sensex over the past week and month, but it has underperformed over the past year and in longer-term comparisons. The stock's year-to-date return of 5.15% is lower than the Sensex's 5.91%, indicating that while there has been some short-term recovery, the overall performance remains weak compared to the broader market. The negative sentiment surrounding the company's long-term growth prospects and financial health, particularly its poor return on equity and declining sales, suggests that investors are cautious, which may be influencing the stock's recent price movement.